You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

CD70-positive advanced/metastatic solid tumors

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Solid Tumor, Adult Trial in Beijing (CD70-targeting CAR-T cells)

Recruiting
  • Solid Tumor, Adult
  • CD70-targeting CAR-T cells
  • Beijing, Iotherapeutic Department Of Chinsese PLA Gereral Hospital, China
    China
Jul 8, 2023

Renal Cell Carcinoma, Ovarian Cancer, Cervix Cancer Trial in Nanchang (CD70 CAR-T cells)

Recruiting
  • Renal Cell Carcinoma
  • +4 more
  • CD70 CAR-T cells
  • Nanchang, Jiangxi, China
    The First Affiliated Hospital of Nanchang University
Aug 23, 2023

Metastatic Tumor, Advanced Solid Tumor, Renal Cell Carcinoma Trial in Zhengzhou (CD70 CAR-T cells)

Recruiting
  • Metastatic Tumor
  • +4 more
  • CD70 CAR-T cells
  • Zhengzhou, Henan, China
    Henan Cancer Hospital
Jul 19, 2022

Metastatic Tumor, Advanced Solid Tumor, Renal Cell Carcinoma Trial in Jinan (CD70 CAR-T cells)

Recruiting
  • Metastatic Tumor
  • +4 more
  • CD70 CAR-T cells
  • Jinan, Shandong, China
    The Second People's Hospital of Shandong Province
Jun 14, 2022

Gastric Cancer, Colon Cancer, Pancreas Cancer Trial in Nanchang (CEA CAR-T cells)

Recruiting
  • Gastric Cancer
  • +6 more
  • CEA CAR-T cells
  • Nanchang, Jiangxi, China
    The First Affiliated Hospital of Nanchang University
Aug 23, 2023

Advanced or Metastatic Solid Tumors Trial in Beijing (CD40 ligand expressing MSLN-CAR T cells, Albumin-bound paclitaxel,

Recruiting
  • Advanced or Metastatic Solid Tumors
  • CD40 ligand expressing MSLN-CAR T cells
  • +2 more
  • Beijing, Beijing, China
    Kaichao Feng
Jan 19, 2023

CD70-positive Advanced Urologic Tumors Trial in Shanghai (Anti-CD70 CAR-T cells)

Recruiting
  • CD70-positive Advanced Urologic Neoplasms
  • Anti-CD70 CAR-T cells
  • Shanghai, Shanghai, China
    Changhai Hospital
Aug 11, 2023

Her2-positive/Low-expression Urinary and Digestive Tract Tumors Trial in Beijing (BL-M07D1)

Not yet recruiting
  • Her2-positive/Low-expression Urinary and Digestive Tract Tumors
  • Beijing, Beijing, China
    Cancer Hospital, Chinese Academy of Medical Sciences
Sep 8, 2023

Solid Tumor, Adult Trial (CF33-CD19 IT, CF33-CD19 IV, Blinatumomab)

Not yet recruiting
  • Solid Tumor, Adult
  • CF33-CD19 IT
  • +2 more
  • (no location specified)
Sep 26, 2023

Solid Tumor Trial in Chuo Ku (SAIL66, Tocilizumab)

Not yet recruiting
  • Solid Tumor
  • Chuo Ku, Tokyo, Japan
    National Cancer Center Hospital
Feb 9, 2023

Advanced Solid Tumors Trial in Guangzhou, Changsha (MRG003+HX008)

Recruiting
  • Advanced Solid Tumors
  • Guangzhou, Guangdong, China
  • +1 more
Jan 15, 2023

Advanced Solid Tumor Trial in Shanghai (RC118, Toripalimab)

Recruiting
  • Advanced Solid Tumor
  • Shanghai, China
    hongshan Hospital Affiliated to Fudan University
Sep 14, 2023

HER2 Positive Advanced Solid Tumors Trial (HypoSti.CAR-HER2 T cells, Albumin-bound paclitaxel, Cyclophosphamide)

Not yet recruiting
  • HER2 Positive Advanced Solid Tumors
  • HypoSti.CAR-HER2 T cells
  • +2 more
  • (no location specified)
Jan 12, 2023

Solid Tumors, Advanced Solid Tumors, Metastatic Solid Tumors Trial (INCA33890)

Not yet recruiting
  • Solid Tumors
  • +2 more
  • (no location specified)
Apr 26, 2023

Advanced Solid Tumor, Advanced Breast Cancer, Metastatic Breast Cancer Trial (BGB-43395, Fulvestrant, Letrozole)

Not yet recruiting
  • Advanced Solid Tumor
  • +8 more
  • (no location specified)
Nov 13, 2023

Advanced Solid Tumor Trial (ES014)

Withdrawn
  • Advanced Solid Tumor
  • (no location specified)
Jan 30, 2023

Locally Advanced Unresectable or Metastatic Solid Tumors Trial in China (SG1906)

Recruiting
  • Locally Advanced Unresectable or Metastatic Solid Tumors
  • Beijing, Beijing, China
  • +8 more
May 12, 2023

HER2-positive Advanced Solid Tumors Trial in Shanghai (DP303c)

Recruiting
  • HER2-positive Advanced Solid Tumors
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Apr 10, 2023

Advanced/Metastatic Solid Tumors Trial in Kurralta Park, Clayton (ADG206)

Not yet recruiting
  • Advanced/Metastatic Solid Tumors
  • Kurralta Park, South Australia, Australia
  • +1 more
Nov 9, 2022

Advanced Solid Tumor Trial in Beijing (SY-3505)

Recruiting
  • Advanced Solid Tumor
  • Beijing, China
    Cancer Hospital, Chinese Academy of Medical Sciences
Sep 15, 2023

Solid Tumor Trial (DR30206)

Not yet recruiting
  • Solid Tumor
  • (no location specified)
Nov 14, 2023

Solid Tumor Trial (BS006 Injection)

Not yet recruiting
  • Solid Tumor
  • BS006 Injection
  • (no location specified)
Jul 3, 2023

Solid Tumors Trial (IBR854 Cell Injection)

Not yet recruiting
  • Solid Tumors
  • IBR854 Cell Injection
  • (no location specified)
Aug 14, 2023

Dabrafenib Plus Trametinib In Rare BRAF V600E Mutation-Positive

Not yet recruiting
  • Rare Unresectable or Metastatic BRAF V600E Mutation-positive Solid Tumors
  • Non-investigational
  • (no location specified)
May 11, 2023

Advanced or Metastatic Solid Tumor, KRAS G12C Mutation Trial in Changsha (BEBT-607Tablets)

Recruiting
  • Advanced or Metastatic Solid Tumor
  • KRAS G12C Mutation
  • Changsha, Hunan, China
    Xiangya Hospital of Central South University
Nov 2, 2023